TRAIL/CD253 Recombinant monoclonal antibody 84280-1-RR proteintech

$149.00
In stock
SKU
84280-1-RR
Catalog No.SizePrice (USD)
84280-1-RR-20UL20 μL$149.00
84280-1-RR-100UL100 μL$449.00
84280-1-RR-10X100UL1 mL (10 x 100 μL vials)$3,592.00
Catalog Number84280-1-RR
SynonymsTNFSF10, TRAIL, 241419C12, Apo-2 ligand, CD253
HostRabbit
Reactivityhuman
FormLiquid
FormulationPBS, Azide, Glycerol
ApplicationsWB, ELISA
Host / IsotypeRabbit / IgG
Tested Applications — Positive WB detected inhuman milk
Recommended Dilutions — Western Blot (WB)WB : 1:5000-1:50000
Positive WB detected inhuman milk
Western Blot (WB)WB : 1:5000-1:50000
Tested Reactivityhuman
ClassRecombinant
TypeAntibody
ImmunogenRecombinant Protein Predict reactive species
Full Nametumor necrosis factor (ligand) superfamily, member 10
Calculated Molecular Weight281 aa, 33 kDa
Observed Molecular Weight22-25 kDa
GenBank Accession NumberBC032722
Gene SymbolTRAIL
Gene ID (NCBI)8743
RRIDAB_3671826
ConjugateUnconjugated
Purification MethodProtein A purification
UNIPROT IDP50591
Storage BufferPBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA.
WB protocol for TRAIL/CD253 antibody 84280-1-RRDownload protocol
Citations-
DilutionsWB : 1:5000-1:50000
IsotypeIgG
ClonalityRecombinant
Clone Number241419C12
ConjugationUnconjugated

TRAIL, also known as CD253 or TNFSF10 (tumor necrosis factor superfamily member 10), is a typical death ligand expressed on natural killer cells and cytotoxic T lymphocytes. This protein preferentially induces apoptosis in transformed and tumor cells, but does not appear to kill normal cells although it is expressed at a significant level in most normal tissues. TRAIL induces apoptotic cell death in cancer by binding to its functional death receptors, death receptor (DR) 4 (TNFRSF10A/TRAIL-R1) and DR5 (TNFRSF10B/TRAIL-R2) to activate the extrinsic apoptosis pathway. TRAIL also activates c-Jun N-terminal kinase (MAPK8/JNK) and the transcription factor nuclear factor-κB (NFκB). The binding of this protein to its receptors has been shown to trigger the activation of MAPK8/JNK, caspase 8, and caspase 3. Protocols Product Specific Protocols WB protocol for TRAIL/CD253 antibody 84280-1-RR Download protocol Standard Protocols Click here to view our Standard Protocols

Product Documents

Datasheet

Reviews

Write Your Own Review
You're reviewing:TRAIL/CD253 Recombinant monoclonal antibody 84280-1-RR proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.